|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01696 SISRAM MED
Nominal 
3.490 +0.010 (+0.287%) | 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Turnover | 365,347 | 4.650% | 349,112 | 359,292 | 354,480 | 294,294 |
| Cost of Sales | (150,203) | 13.419% | (132,432) | (139,767) | (152,254) | (127,433) |
| Gross Profit | 215,144 | -0.709% | 216,680 | 219,525 | 202,226 | 166,861 |
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 210 | 600.000% | 30 | (421) | (521) | (307) | |
| Profit / (Loss) before Taxation | 28,550 | -12.265% | 32,541 | 37,130 | 44,242 | 41,672 | |
| Taxation | (3,545) | -6.093% | (3,775) | (4,232) | (4,162) | (9,152) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (5,989) | 64.533% | (3,640) | (1,399) | 90 | (1,275) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 19,016 | -24.317% | 25,126 | 31,499 | 40,170 | 31,245 | |
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Net Finance Costs / (Income) | 2,284 | 37.177% | 1,665 | 1,842 | 1,359 | 1,462 |
| Depreciation & Amortisation | 17,349 | 0.248% | 17,306 | 14,235 | 12,402 | 12,285 |
| Directors' Emoluments | -- | -- | 1,608 | 1,681 | 2,565 | 1,711 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 4.060 | -24.254% | 5.360 | 6.740 | 8.620 | 6.900 |
| DPS (cts) | 1.213 | -- | 1.622 | 2.020 | 2.204 | 2.008 |
| Dividend Payout Ratio (%) | 29.875% | -- | 30.257% | 29.973% | 25.574% | 29.106% |
| Cash flow per share ($) | -- | -- | 0.071 | 0.094 | 0.047 | 0.072 |
| NBV per share ($) | 1.025 | -- | 0.991 | 0.966 | 0.922 | 0.863 |
| Remarks: | Real time quote last updated: 25/03/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD 19,016 |
| %Change | -24.317% |
| EPS / (LPS) | USD 0.041 |
| NBV Per Share ($) | USD 1.025 |